Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsRaw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tg Therapeutics (TGTX) Treasury Shares: 2016-2025

Historic Treasury Shares for Tg Therapeutics (TGTX) over the last 10 years, with Sep 2025 value amounting to $100.2 million.

  • Tg Therapeutics' Treasury Shares rose 4106.21% to $100.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $100.2 million, marking a year-over-year increase of 4106.21%. This contributed to the annual value of $9.0 million for FY2024, which is 3743.59% up from last year.
  • Per Tg Therapeutics' latest filing, its Treasury Shares stood at $3.5 million for Q3 2025, which was up 365.60% from $761,098 recorded in Q2 2025.
  • In the past 5 years, Tg Therapeutics' Treasury Shares registered a high of $12.1 million during Q3 2024, and its lowest value of $41,309 during Q1 2021.
  • In the last 3 years, Tg Therapeutics' Treasury Shares had a median value of $367,903 in 2024 and averaged $2.5 million.
  • Data for Tg Therapeutics' Treasury Shares shows a peak YoY spiked of 9,298.29% (in 2025) over the last 5 years.
  • Quarterly analysis of 5 years shows Tg Therapeutics' Treasury Shares stood at $234,000 in 2021, then remained steady at $234,000 in 2022, then remained steady at $234,000 in 2023, then spiked by 3,743.59% to $9.0 million in 2024, then soared by 4,106.21% to $100.2 million in 2025.
  • Its last three reported values are $100.2 million in Q3 2025, $22.0 million for Q2 2025, and $15.1 million during Q1 2025.